Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07226128 · ClinicalTrials.gov registry record · NA

The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV

A NA study, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target

NCT07226128: Recruiting NA study, sponsored by Indiana University.

NCT07226128 is a NA study that is actively recruiting participants, run by Indiana University. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07226128, a NA study, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if depression treatment improves insulin resistance, or how the body uses insulin to lower blood sugar, in people with HIV on HIV treatment. Researchers will compare an internet-based (online) depression treatment program called cognitive behavioral therapy with depression education. In the online group, participants will undergo 9 weekly treatment sessions. The education group will receive learning materials about depression and will be monitored every month. All participants will have 4 study visits over 12 months.

Primary Outcome

Homeostasis Model Assessment-Insulin, where higher values indicate greater insulin resistance

Interventions

  • BEHAVIORAL Internet cognitive behavioral therapy (iCBT-D)
  • BEHAVIORAL Active Control (AC)

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2026-04-10
Est. Completion 2031-06-30
Phase NA
Indiana University

890 total trials

What NCT07226128 shows while recruiting

NCT07226128 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Internet cognitive behavioral therapy (iCBT-D) is the first listed.

NCT07226128 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07226128 about?

NCT07226128 is a clinical study titled "The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV". The goal of this clinical trial is to learn if depression treatment improves insulin resistance, or how the body uses insulin to lower blood sugar, in people with HIV on HIV treatment. Researchers will compare an internet-based (online) depression treatment program called cognitive behavioral therap...

What is the current status of trial NCT07226128?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-04-10. Estimated completion is 2031-06-30.

What interventions are being tested in trial NCT07226128?

The interventions under investigation include: Internet cognitive behavioral therapy (iCBT-D) (BEHAVIORAL), Active Control (AC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07226128?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07226128's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07226128, the US trial registry maintained by the National Library of Medicine. NCT07226128 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.